Athira Pharma, makers of experimental Alzheimer’s drug fosgonimeton, paid up $4 million to settle a federal case following allegations that the company manipulated scientific … Continue reading Alzheimer’s Drugmaker Athira Shells Out $4 Million In DOJ Settlement